Effect of BRD4 Inhibitor GSK525762A on Proliferation and Apoptosis of SUP-B15 Cells In Vitro and Its Possible Mechanism.
- Author:
Xue WANG
1
;
Na QI
1
;
Sha MA
2
;
Zhi-Ling YAN
2
;
Qing-Yun WU
1
;
Lin WANG
1
;
Chong CHEN
3
;
Kai-Lin XU
4
,
5
Author Information
- Publication Type:Journal Article
- From: Journal of Experimental Hematology 2016;24(6):1654-1658
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the effect of BRD4 inhibitor GSK525762A on the proliferation and apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia SUP-B15 cells and its mechanism.
METHODSSUP-B15 cells were treated with different concentration of GSK525762A, the proliferation-inhibition curve was assayed and plotted by CCK-8 method, the cell viability and apoptosis were detected by flow cytometry with Annexin V and 7-AAD staining. The transcripts of anti-apoptotic genes C-MYC, CDK6 and BCL-2 were detected by real-time PCR.
RESULTSGSK525762A could inhibit significantly SUP-B15 cell proliteration in dose-and time-dependent manner; GSK525762A treatment could induce apoptosis of SUP-B15 cells. The levels of C-MYC,CDK6 and BCL-2 mRNA transcripts in SUP-B15 cells were reduced in GSK525762A-treated group.
CONCLUSIONThe GSK525762A can remarkably inhibit proliferation and induce apoptosis of SUP-B15 cells. The down-regulation of apoptosis-related genes C-MYC,CDK6 and BCL-2 may be involved in the process of apoptosis.
